|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.
The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by SVB Leerink on January 14, 2022. The analyst firm set a price target for 16.00 expecting FOLD to rise to within 12 months (a possible 75.25% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $9.13 last updated Fri Jan 28 2022 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Amicus Therapeutics.
Amicus Therapeutics’s $Q4 earnings are confirmed for after-market on February 28, 2022.
There is no upcoming split for Amicus Therapeutics.
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.